Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "ISA"

1403 News Found

IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration
Policy | April 25, 2026

IPC signs MoUs with PMBI, NIPER Hajipur to boost drug quality, pharmacovigilance and research collaboration

The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India


NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research
Policy | April 25, 2026

NIPER Hajipur, Boehringer Ingelheim India ink MoU to boost translational pharma research

As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.


India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh
Policy | April 25, 2026

India’s bio-economy to hit $1 trillion by 2047: Dr Jitendra Singh

At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones


Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement
Public Health | April 25, 2026

Indian firm hosts global homoeopathy summit at UK Parliament amid rising global engagement

The summit brought together over 150 doctors, researchers, and practitioners worldwide


India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem
Public Health | April 25, 2026

India Autism Center hosts ‘Sports for All’ initiative to advance inclusive sporting ecosystem

Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms


Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens
Supply Chain | April 25, 2026

Azelis posts resilient Q1 as acquisitions mask organic slowdown and cash flow strengthens

Profitability came under strain. Gross profit fell to EUR 246m, with margins narrowing to 23.7% as negative product mix—particularly in Asia Pacific—weighed on performance


Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples
R&D | April 24, 2026

Takara Bio, Resistomap join forces to streamline AMR surveillance from environmental samples

Collaboration integrates SmartChip PCR technology with cloud-based analytics to enable faster, standardised monitoring of antimicrobial resistance


Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million
News | April 24, 2026

Gujarat Themis Biosyn to acquire anti-TB and anti-infective brands from Sanofi for EUR 158 Million

Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence


IMCD appoints Angelique Kruif as Global People Director
People | April 23, 2026

IMCD appoints Angelique Kruif as Global People Director

Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations


Motorica India CRE programme enhances clinician training and patient-centric prosthetic care
Healthcare | April 23, 2026

Motorica India CRE programme enhances clinician training and patient-centric prosthetic care

Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development